SD

Srikanth Dandamudi

Active Director Director DIN 02663890
DIN 02663890 First appointment May 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since May 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Srikanth Dandamudi

Data last updated:

Srikanth Dandamudi is a Director at Sionc Pharmaceuticals Private Limited (since 2009) and Managing Director at Sionc Laboratories Private Limited (since 2021). The companies operate in Pharma. The largest current company by reported revenue is Sionc Pharmaceuticals Private Limited at ₹148 Cr (FY 2024). Earlier, Srikanth Dandamudi was a Director at Quagen Pharma India Private Limited (2015–2024) and Director at Sintezon Labs Private Limited (from 2015).

DIN 02663890
Primary Designation Director
Industry Pharma
First Appointment 21 May 2009
Oldest Company Age 18 yrs
Largest company Sionc Pharmaceuticals Private Limited Β· ₹148 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 May 20092008₹148 Cr (FY 2024)Active
Sionc Laboratories Private Limited U24299AP2021PTC117064
Managing Director11 Jan 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Quagen Pharma India Private Limited U74900AP2015FTC096297
Director21 Apr 20152015₹3.9 Lakh (FY 2018)Active
Sintezon Labs Private Limited U74900AP2015PTC097102
Director04 Aug 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sionc Pharmaceuticals Private Limited
Sionc Laboratories Private Limited
Sintezon Labs Private Limited
Quagen Pharma India Private Limited
Premium access

Shareholding and investment profile for Srikanth Dandamudi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srikanth Dandamudi

Srikanth Dandamudi currently holds 2 directorships: Sionc Pharmaceuticals Private Limited (Director, since 21 May 2009, revenue β‚Ή148 Cr (FY 2024)); Sionc Laboratories Private Limited (Managing Director, since 11 Jan 2021).

Srikanth Dandamudi was first appointed on 21 May 2009 as Director at Sionc Pharmaceuticals Private Limited. The most recent appointment on record is 11 Jan 2021 at Sionc Laboratories Private Limited.

Srikanth Dandamudi held 2 earlier board appointments: Quagen Pharma India Private Limited (Director, 21 Apr 2015 to 06 Sep 2024); Sintezon Labs Private Limited (Director, from 04 Aug 2015).

The current boards of Srikanth Dandamudi's companies include Baburao Dandamudi (Sionc Pharmaceuticals Private Limited), Jagadeesh Babu Rangisetty (Sionc Pharmaceuticals Private Limited), Manikreddy Pullagurla (Sionc Pharmaceuticals Private Limited), Subba Rao Jetti (Sionc Pharmaceuticals Private Limited), Suman Lahoti (Sionc Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available